Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where M. Rosa Sanabria is active.

Publication


Featured researches published by M. Rosa Sanabria.


Ophthalmologica | 2012

Pathology associated with optical coherence tomography macular bending due to either dome-shaped macula or inferior staphyloma in myopic patients.

Rosa M. Coco; M. Rosa Sanabria; Javier Alegría

Purpose: To evaluate the prevalence of and describe the pathology associated with macular bending (MB) defined as a smooth macular elevation found in optical coherence tomography (OCT) of patients with high myopia related to either dome-shaped macula (DSM) or the border of an inferior staphyloma. Procedures: We reviewed the 330 files of all highly myopic patients in our database that had had an OCT performed in the last 5 years. Main outcome measures were MB prevalence and its associated pathology. Results: Sixty-eight eyes from 45 patients (13.63%) presented MB; 23 bilateral, 40 in a posterior pole or macular staphyloma and 21 in an inferior staphyloma. Eighteen eyes presented choroidal neovascularization (CNV), 7 subretinal fluid without CNV, 11 retinoschisis and 3 a macular hole which had been stable for years. No differences were found in the rate of complications between patients with DSM or inferior staphyloma. Conclusions: MB is not an uncommon clinical feature. Associated pathology prevalence in MB was elevated and similar in posterior and inferior staphylomas.


Ocular Immunology and Inflammation | 2007

Photodynamic Therapy for Subfoveal and Juxtafoveal Choroidal Neovascularization Associated with Punctate Inner Choroidopathy

Rosa M. Coco; Clairton Feitosa de Souza; M. Rosa Sanabria

Purpose: To evaluate the treatment of subfoveal and juxtafoveal choroidal neovascularization (CNV) using verteporfin photodynamic therapy (vPDT) in patients affected by punctate inner choroidopathy (PIC). Methods: A chart review of 8 patients with CNV associated with PIC treated with vPDT was done. Results: The 8 patients (8 eyes) included 4 men and 4 women with a mean age of 30.9 years. Six of them presented juxtafoveal CNVs, and two had subfoveal CNVs, at presentation. Mean follow-up time was 22.7 months. The VA improved in five eyes, and three eyes declined. One patient developed a new CNV a few days after vPDT, and one had multiple CNVs at presentation. Two of the 3 patients with longer follow-up period presented late recurrences. Conclusions: vPDT is a beneficial resource in stabilizing and also improving VA in PIC patients affected with subfoveal and juxtafoveal CNV, although one third of the patients retain poor visual acuity.


Ophthalmologica | 2012

Retinal Pigment Epithelium Tears in Age-Related Macular Degeneration Treated with Antiangiogenic Drugs: A Controlled Study with Long Follow-Up

Rosa M. Coco; M. Rosa Sanabria; Arturo G. Hernandez; Marta Fernández Muñoz

Purpose: To study whether anti-vascular endothelial growth factor (VEGF) therapy improves visual acuity (VA) in patients with exudative age-related macular degeneration (AMD) complicated with retinal pigment epithelium (RPE) tears. Methods: Retrospective case-control series. Group I (control group) included 9 patients with RPE tears that received no treatment, and group II (intervention group) incorporated 12 patients treated with anti-VEGF. Results: A statistically significant difference was found in VA between the groups from the 3rd month to the final follow-up (p = 0.034). Final VA improved in the treatment group (p = 0.015). No differences were found in central macular thickness between the groups either before or after treatment. Mean number of injections in group II was 5.75 (SD = 1.19). Most patients presented a grade 3 rip. All lesions were inactive at the end of follow-up in group II and 1 remained active in group I. The number of final atrophic/disciform scars was 6/8 in group I and 7/5 in group II. Conclusions: RPE tears treated with antiangiogenic drugs experienced functional benefit. To the authors’ knowledge, this is the first controlled series reporting effectiveness of suppression of neovascular activity with antiangiogenic treatment after RPE rip in AMD.


BMC Ophthalmology | 2014

Funduscopic results after 4-year follow-up treatment with ranibizumab for age-related macular degeneration in a region of Spain

Rosa M. Coco; M. Rosa Sanabria; Melissa Castrejon; M. Isabel López-Gálvez; Laura Monje-Fernandez; Marta Fernandez-Munoz; Alejandro Anton; Lourdes de Juan-Marcos; Sonia Villaron-Alvarez; Itziar Fernández

BackgroundThe study aims to survey longstanding funduscopic and functional outcomes of age-related macular degeneration (AMD) after ranibizumab treatment and verify the accuracy of a new method to compare the retinal thickness measured with different optical coherence tomography (OCT) tools.MethodsCase series included 314 eyes with 2–4 years of follow-up. Main Outcome Measures were visual acuity (VA), number of injections, retinal thickness, OCT morphology, and final macular funduscopic status.ResultsOne hundred twenty-two men and 177 women (mean age, 78.3 years) were included. The mean time to the first injection was 17.3 ± 14.6 days. Initial VA was O.8(20/125) ± 0.5; 0.7(20/100) ± 0.5 at 3 months; 0.8(20/125) ± 0.5 at a year; 1(20/200) ± 0.6 at year 2; 1(20/200) ± 0.6 at year 3 and 1.1(20/250) ± 0.6 at year 4. Number of visits at 3 months was 2.7 ± 0.8; 7.3 ± 2.1 at a year; 5.2 ± 2.7 along the 2nd year; 3.9 ± 2.3 at year 3 and 3.6 ± 2.2 at year 4. Number of injections at 3 months was 2.6 ± 0.5; 3.9 ± 1.5 at a year; 1.1 ± 1.5 along the 2nd year; 1.5 ± 2.4 at year 3 and 1.8 ± 3.1 at year 4. Patients with worse VA outcomes received more injections and were older. The formula to calculate changes in retinal thickness showed a 30% reduction in thickness, which correlated well with the OCT morphology. Patients with polypoidal choroidal vasculopathy (PCV) had a worse final outcome. The final disciform macular status (37%) was related to fewer injections and a greater decrease in thickness. Final well-preserved maculas (12.%) needed more injections and treatment changes; those that were atrophic at the final visit (30.8%) had a worse initial VA and greater decrease in thickness at the 3-month visit.ConclusionsYounger patients had better final outcomes. Our method to compare retinal thickness using different OCT tools worked well. The final visual outcome after a long follow-up was poor, which may be related to advanced age, poor initial VA, and the high incidence of final fibrosis or atrophy.


Journal of Ophthalmology | 2013

Autofluorescence Images with Carl Zeiss versus Topcon Eye Fundus Camera: A Comparative Study.

Juan M. Muñoz; Rosa M. Coco; M. Rosa Sanabria; Rubén Cuadrado; Eduardo Blanco

Purpose. To compare the autofluorescence images of the Zeiss versus Topcon eye fundus cameras and design an objective way to quantify it. Procedures. The IMAGEJ software was used to determine the gray level corresponding to the darkest veins and the peripapillary ring (thresholds), the level of white of the brightest perifoveal area, their difference (contrast level), and the suprathreshold area for each photograph. Results. Carl Zeiss has higher contrast values than Topcon. The Topcon contrast presented a crest with further decline as the suprathreshold area continued to increase. On the contrary, the Zeiss profile did not decline in contrast. Conclusions and Message. The Carl Zeiss camera showed superior contrast ability over the Topcon when performing autofluorescence imaging. We set objective parameters to compare fundus cameras FAF images. These parameters could be the base to objectively measure and determine changes and realize followup to areas of hyper- or hypofluorescence.


BMC Ophthalmology | 2017

Predictive models of long-term anatomic outcome in age-related macular degeneration treated with as-needed Ranibizumab

Lucia Gonzalez-Buendia; Santiago Delgado-Tirado; M. Rosa Sanabria; Itziar Fernández; Rosa M. Coco


Investigative Ophthalmology & Visual Science | 2016

PREDICTIVE MODELS OF LONG-TERM ANATOMIC OUTCOME IN EXUDATIVE AMD TREATED WITH AS-NEEDED RANIBIZUMAB

Lucia Gonzalez-Buendia; Santiago Delgado-Tirado; M. Rosa Sanabria; Itziar Fernández; Rosa M. Coco


Investigative Ophthalmology & Visual Science | 2015

PREDICTIVE FACTORS OF VISUAL IMPROVEMENT IN EXUDATIVE AMD PATIENTS AFTER 4 YEARS OF AS NEEDED RANIBIZUMAB TREATMENT

Lucia Gonzalez-Buendia; M. Rosa Sanabria; I. Fernández; Santiago Delgado-Tirado; Rosa M. Coco


Medical Education | 2012

E‐learning strategies to improve general practitioners’ knowledge of age‐related macular degeneration

Rosa M. Coco; M. Rosa Sanabria; Itziar Fernández


Investigative Ophthalmology & Visual Science | 2011

Comparison Of The Efficacy Of 1%, 5% Or 10% Povidone-iodine (PVI) Irrigation In Combination With Levofloxacin 0.3% As Prophylaxis In Patients Undergoing Cataract Surgery

Adriana Caballero; Verónica Castillo; Margarita Samudio; Norma Fariña; A. Carron; Herminia Miño de Kaspar; Florentina Laspina; Sonia Abente; M. Rosa Sanabria; D Cibils

Collaboration


Dive into the M. Rosa Sanabria's collaboration.

Top Co-Authors

Avatar

Rosa M. Coco

University of Valladolid

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge